| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016999067 |
| P356 | DOI | 10.1186/1471-2172-12-23 |
| P932 | PMC publication ID | 3078900 |
| P698 | PubMed publication ID | 21435210 |
| P5875 | ResearchGate publication ID | 50849666 |
| P50 | author | Stefan Nierkens | Q55603425 |
| Gosse J Adema | Q89268769 | ||
| P2093 | author name string | Judith M Bolscher | |
| Liza W Toonen | |||
| Roger P M Sutmuller | |||
| Wendy W C van Maren | |||
| P2860 | cites work | Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide | Q24294695 |
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| Toll-like receptor 2 controls expansion and function of regulatory T cells | Q34264024 | ||
| Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
| Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells | Q34557118 | ||
| Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival | Q34611787 | ||
| From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias | Q36270262 | ||
| Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors | Q36726933 | ||
| Toll or toll-free adjuvant path toward the optimal vaccine development | Q36763663 | ||
| TLR2 is expressed on activated T cells as a costimulatory receptor | Q36853515 | ||
| TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity | Q37136130 | ||
| Legionella lipoprotein activates toll-like receptor 2 and induces cytokine production and expression of costimulatory molecules in peritoneal macrophages | Q37411194 | ||
| Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression | Q38305109 | ||
| Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model | Q39172615 | ||
| Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells. | Q47873397 | ||
| Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells | Q47991722 | ||
| Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. | Q54435250 | ||
| The synthetic analogue of mycoplasmal lipoprotein FSL-1 induces dendritic cell maturation through Toll-like receptor 2. | Q54472029 | ||
| TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity | Q62081996 | ||
| Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2 | Q78664540 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| Toll-like receptor 2-mediated dendritic cell activation by a Porphyromonas gingivalis synthetic lipopeptide | Q79997328 | ||
| Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection | Q82738199 | ||
| TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells | Q83155013 | ||
| Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands | Q83986858 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 23 | |
| P577 | publication date | 2011-03-24 | |
| P1433 | published in | BMC Immunology | Q2877163 |
| P1476 | title | Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation | |
| P478 | volume | 12 |
| Q40305947 | Hyaluronan is not a ligand but a regulator of toll-like receptor signaling in mesangial cells: role of extracellular matrix in innate immunity. |
| Q47095275 | IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases |
| Q39072247 | Innate immunity against Legionella pneumophila during pulmonary infections in mice |
| Q28081922 | Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells |
| Q37961175 | Regulatory T cells in infection |
| Q36970905 | Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver |
| Q41193010 | TLR-2 Signaling Promotes IL-17A Production in CD4+CD25+Foxp3+ Regulatory Cells during Oropharyngeal Candidiasis |
| Q35176439 | The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells |
| Q27001581 | The effects of TLR activation on T-cell development and differentiation |
| Q38203260 | Toll-Like Receptor Activation in Immunity vs. Tolerance in Autoimmune Diabetes. |
| Q41067125 | Toll-like receptor 2 activators modulate oral tolerance in mice. |
| Q38259531 | Toll-like receptor 2 as a regulator of oral tolerance in the gastrointestinal tract. |
Search more.